http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2015059220-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_116c851e729089df9a427027272fa290 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1040131367ea3c09a7c2697009efef69 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-337 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-179 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-3955 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
| filingDate | 2014-10-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_58df28becb0af1c1ce0984534f4f02a5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6ae9c3df993391b98d0227eb0f232876 |
| publicationDate | 2015-04-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | WO-2015059220-A1 |
| titleOfInvention | Use of aflibercept and docetaxel for the treatment of nasopharyngeal carcinoma |
| abstract | The present invention concerns a polypeptide comprising SEQ ID NO: 1 or a biosimilar thereof, and a combined preparation or a composition comprising a polypeptide comprising SEQ ID NO: 1 or a biosimilar thereof and docetaxel, for use for treating patients with nasopharyngeal carcinoma. The invention also pertains to an article of manufacture comprising a packaging material, a polypeptide of SEQ ID NO: 1, or a biosimilar thereof, and a label or package insert contained within said packaging material indicating that the polypeptide or biosimilar thereof is indicated for patients with nasopharyngeal carcinoma. The invention further relates to a safe therapeutic dose of a polypeptide comprising SEQ ID NO: 1 or a biosimilar thereof, in combination with docetaxel, for use for treating patients with nasopharyngeal carcinoma. In one embodiment, the polypeptide is aflibercept. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11155610-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11066465-B2 |
| priorityDate | 2013-10-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 155.